Isothermal hot compression tests of two promising new titanium alloys (Ti‐10 V‐1Fe‐3Al and Ti‐10 V‐2Cr‐3Al) are performed using a TA DIL805D deformation dilatometer at temperatures in and above the two‐phase α + β region (730–880 °C) at strain rates ranging from 10−3 to 10−1 s−1. Results show that the flow stress of the two alloys decreases with increasing deformation temperature and decreasing strain rate. Some of the flow curves manifest clear discontinuous yielding and flow softening, both of which are strongly affected by the deformation conditions. The flow stress behavior of these two alloys can be described very well by a hyperbolic–sine Arrhenius equation. When deforming in the α + β phase region, the deformation mechanism is governed by the bending or globularization of the α phase. When deforming in the pure β phase field, the flow behavior is mainly determined by dynamic recovery or recrystallization. The difference in alloy composition has a minor effect on their hot working behavior.
To investigate the thermal deformation behavior of Ti–10V–2Cr–3Al titanium alloy, the hot compression experiments were carried out via a strain rate of 0.1 s−1–0.001 s−1 and deformation temperature of 730 ℃~880 ℃. The results showed that the rheological stress decreases when the deformation temperature increases or strain rate decreases. Due to the deformation conditions, some flow curves exhibited significant discontinuous yielding and flow softening. Flow softening in the α+β phase region was dominated by dynamic recrystallization (DRX), while in the β phase region, it was centered on dynamic recovery (DRV). A high-temperature constitutive equation, with good predictive power, was established.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.